Authors:
Keefe, KA
Schell, MJ
Brewer, C
McHale, M
Brewster, W
Chapman, JA
Rose, GS
McMeeken, DS
Lagerberg, W
Peng, YM
Wilczynski, SP
Anton-Culver, H
Meyskens, FL
Berman, ML
Citation: Ka. Keefe et al., A randomized, double blind, phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia, CANC EPID B, 10(10), 2001, pp. 1029-1035
Authors:
Alberts, DS
Dorr, RT
Einspahr, JG
Aickin, M
Saboda, K
Xu, MJ
Peng, YM
Goldman, R
Foote, JA
Warneke, JA
Salasche, S
Roe, DJ
Bowden, GT
Citation: Ds. Alberts et al., Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine, CANC EPID B, 9(12), 2000, pp. 1281-1286
Authors:
Lopez, AM
Ketchum, M
Nichols, H
Xu, MJ
Peng, YM
Dorr, R
Alberts, DS
Citation: Am. Lopez et al., A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignancies, CANC CHEMOT, 46(5), 2000, pp. 411-415
Authors:
Duan, SB
Liu, FY
Luo, JA
Wu, HW
Liu, RH
Peng, YM
Yang, XL
Citation: Sb. Duan et al., Nephrotoxicity of high- and low-osmolar contrast media - The protective role of amlodipine in a rat model, ACT RADIOL, 41(5), 2000, pp. 503-507
Citation: Sb. Duan et al., Assessment of urinary endothelin-1 and nitric oxide levels and their relationship with clinical and pathologic types in primary glomerulonephritis, YONSEI MED, 40(5), 1999, pp. 425-429
Citation: T. Masui et al., Reduction behavior of CeO2-ZrO2 solid solution prepared from cerium zirconyl oxalate, CHEM MATER, 10(12), 1998, pp. 4005-4009
Authors:
Weiss, GR
Liu, PY
Alberts, DS
Peng, YM
Fisher, E
Xu, MJ
Scudder, SA
Baker, LH
Moore, DF
Lippman, SM
Citation: Gr. Weiss et al., 13-cis-retinoic acid or all-trans-retinoic acid plus inteferon-alpha in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial, GYNECOL ONC, 71(3), 1998, pp. 386-390